| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. | Chief Legal Officer | Common Stock | 3,634 | $14,899 | $4.10 | 10 Dec 2025 | Direct |
| Avalo Therapeutics, Inc. | Chief Legal Officer | Stock Option (Right to Buy) | 100,000 | 28 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | 10 Dec 2025 | 1 | -$4,166 | 4 | Chief Legal Officer | 12 Dec 2025, 16:17 |
| AVTX | Avalo Therapeutics, Inc. | 28 Jan 2025 | 1 | $0 | 4 | Chief Legal Officer | 30 Jan 2025, 17:51 |
| AVTX | Avalo Therapeutics, Inc. | 24 Jun 2024 | 1 | $0 | 4 | Chief Legal Officer | 25 Jun 2024, 16:08 |
| AVTX | Avalo Therapeutics, Inc. | 24 Jun 2024 | 0 | $0 | 3 | Chief Legal Officer | 25 Jun 2024, 16:01 |